GlassScriptPhysician profile
Derek A Taggard
NPI 1548242589
$93,890.60
in general payments reported to CMS, 2019-2025
12 companies · $24K in 2025
The $24K reported for 2025 was more than what 91% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14K · 2020: $10K · 2021: $8,557 · 2022: $16K · 2023: $11K · 2024: $10K · 2025: $24K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $27K · Travel and Lodging: $7,222 · Consulting Fee: $6,800 · Food and Beverage: $4,250.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $26,996.00 |
| Travel and Lodging | $7,222.40 |
| Consulting Fee | $6,800.00 |
| Food and Beverage | $4,250.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nexxt Spine LLC | $56,596.40 | 2019-2025 | Saxxony System |
| Spineart USA INC | $30,724.44 | 2021-2025 | Perla Tl, Perla C, Cure Acp |
| Degen Medical, INC. | $4,964.06 | 2021 | |
| Synthes Gmbh | $1,053.69 | 2019 | |
| Spineart Sa | $229.42 | 2022 | |
| Ecential Robotics | $181.68 | 2024 | |
| Medtronic, INC. | $46.67 | 2021 | |
| Stryker Corporation | $44.66 | 2024 | Bio4, Capri Corpectomy Cage System |
| Depuy Synthes Sales INC. | $31.10 | 2021 | |
| Abbott Laboratories | $18.48 | 2024 | Eterna |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Derek Taggard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.